Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Breast Cancer

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Better Outcomes for Cancer Patients Begin with Screening

Diagnostics

Better Outcomes for Cancer Patients Begin with Screening

BCAL DIagnostics

PAO-11-24-RTM-09Nov 15, 2024

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Antibody–Drug Conjugates

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Loretta Itri, M.D., F.A.C.P.,; Usama Malik

Immunomedics

PAP-Q2-20-CL-012Jul 01, 2020

U.S. Food & Drug Administration

FDA Approval

FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer

U.S. Food & Drug Administration

PR-M07-18-NI-095Jul 27, 2018

Hormone Therapy Appears to Be the Best Bet for Treating Early Breast Cancer

Oncology

Hormone Therapy Appears to Be the Best Bet for Treating Early Breast Cancer

Emilie Branch

Pharma's Almanac

PAO-M06-18-NI-011Jun 14, 2018

FDA Recommends Approval of Trastuzumab Biosimilar

Biosimilar

FDA Recommends Approval of Trastuzumab Biosimilar

Guy Tiene

Nice Insight

PAO-M07-17-NI-025Jul 21, 2017

Lilly’s Breast Cancer Treatment Granted Priority Review

FDA

Lilly’s Breast Cancer Treatment Granted Priority Review

Steve Kuehn

Nice Insight

PAO-M07-17-NI-019Jul 13, 2017